Long-Term Outcomes and Rehabilitation in...

Dr. Jessica Ailani and Dr. Kathleen Digre discuss three key updates in the understanding and management of idiopathic intracranial hypertension. Show references: https://jamanetwork.com/journals/jamaneurology/article-abstract/2836065 https://www.neurology.org/doi/10.1212/WNL.0000 ... Show More

Dr. Andy Southerland and Dr. Amrou Sarraj examine whether general anesthesia (GA) compared with non-GA was associated with better functional outcomes in the SELECT2 trial. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000213819 

In the October episode of the President's Spotlight, Dr. Jason Crowell talks with Dr. Natalia Rost about the crucial role research plays in neurology for clinicians and scientists. Show reference: https://www.aan.com/about-the-aan/presidents-spotlight 

Dr. Justin Abbatemarco talks with Dr. Ahmad Nehme about the complexities of diagnosing and differentiating between Cerebral amyloid angiopathy-related inflammation and biopsy-positive primary angiitis of the central nervous system. Read the related article in Neurology. Disclosur ... Show More

In this episode, we speak with Dr. Melody Porlier and Dr. Arpana Jain, co-authors of a case exploring the interaction of traumatic injury and rising infectious disease risks. Check out their written case (adaptable for medical school curricula) at Climate Resources for health edu ... Show More

Dr. Amy Attaway and Dr. Dan Culver review the emerging relationship between COPD patients who have intermittent hypoxemia and an increase they have in co-morbidities and mortality. They discuss how multiple associative studies suggest that intermittent hypoxemia may impact muscul ... Show More

Interview with Jennifer M. Johnson, MD, PhD and Adam J. Luginbuhl, MD authors of A Pathologic Treatment Effect and Survival in HPV-Negative HNSCC Following Neoadjuvant Nivolumab. Hosted by Paul C. Bryson, MD MBA. Related Content: Pathologic Treatment Effect and Survival in HPV-Ne ... Show More

BSA, MIRD, or voxel-based dosimetry? Join us for part 2 of Dosimetry University where interventional oncologists Dr. Tyler Sandow, Dr. Nima Kokabi, and Dr. Kavi Krishnasamy explore and debate the critical nuances of a successful Y90 procedure, covering dosing methods, lung shunt ... Show More

Host Dr. Ben Young invites Drs. Roni Levin and Evan Silverstein to review the current state of amblyopia treatment, ranging from the mainstays of patching and atropine drops to novel advances such as dichoptic therapy. Below are some references regarding dichoptic therapy that we ... Show More

Five articles from the July 2025 issue summarized in five minutes, with the addition of a brief editorial commentary. The 5-in-5 feature is designed to give readers an overview of articles that may pique their interest and encourage more detailed reading. It may also be used by b ... Show More

Today’s episode will focus on an update for commonly tested Thrombotic microangiopathies (TMA) such as Thrombotic Thrombocytopenic Purpura (TTP). This will include the high yield facts on mechanism, presentation, diagnostic work-up, and treatment of TTP, and also discuss Hemolyti ... Show More

Hyperbaric oxygen is out and surgical innovation is in—here’s how the rescue flap is reshaping ORN care. Facial plastic and microvascular surgeons Dr. Ariel Frost and Dr. Eli Gordin join host Dr. Ashley Agan to discuss osteoradionecrosis (ORN) of the mandible.---SYNPOSISThe discu ... Show More

Dr. Centor discusses outcomes in patients with type 2 diabetes when treated with semaglutide or dulaglutide versus empagliflozin with Drs. Kevin Kip and Anum Saeed.